Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education.

Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy JP, Rueda S, Abdallah SJ, Jensen D, Lebouché B, Brouillette MJ, Klein M, Szabo J, Frenette C, Giannakis A, Jenabian MA.

Cannabis Cannabinoid Res. 2019 Sep 23;4(3):204-213. doi: 10.1089/can.2018.0068. eCollection 2019.

PMID:
31579835
2.

Plasma levels of C-type lectin REG3α and gut damage in people with HIV.

Isnard S, Ramendra R, Dupuy FP, Lin J, Fombuena B, Kokinov N, Kema I, Jenabian MA, Lebouché B, Costiniuk CT, Ancuta P, Bernard NF, Silverman MS, Lakatos PL, Durand M, Tremblay C, Routy JP; Montreal primary HIV infection study; Canadian cohort of HIV+ slow progressors; Canadian HIV and Aging cohort groups.

J Infect Dis. 2019 Aug 23. pii: jiz423. doi: 10.1093/infdis/jiz423. [Epub ahead of print]

PMID:
31504638
3.

Differential influence of race and environment on indeterminate reactivities to non-treponemal and treponemal antigens by immuno-chromatographic dual syphilis rapid test.

Mbopi-Keou FX, Kalla GCM, Voundi EV, Jenabian MA, Bouassa RM, Talla F, Angwafo FF 3rd, Belec L.

Pan Afr Med J. 2019 Jun 6;33:90. doi: 10.11604/pamj.2019.33.90.16437. eCollection 2019.

4.

Cannabinoids and inflammation: Implications for People Living with HIV.

Costiniuk CT, Jenabian MA.

AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345. [Epub ahead of print]

PMID:
31408029
5.

Differential Dynamics of Regulatory T-Cell and Th17 Cell Balance in Mesenteric Lymph Nodes and Blood following Early Antiretroviral Initiation during Acute Simian Immunodeficiency Virus Infection.

Yero A, Farnos O, Rabezanahary H, Racine G, Estaquier J, Jenabian MA.

J Virol. 2019 Sep 12;93(19). pii: e00371-19. doi: 10.1128/JVI.00371-19. Print 2019 Oct 1.

6.

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment.

Salahuddin S, Thomson E, Méziane O, Farnos O, Pagliuzza A, Chomont N, Olivenstein R, Costiniuk C, Jenabian MA.

J Vis Exp. 2019 Jun 23;(148). doi: 10.3791/59427.

PMID:
31282892
7.

HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy.

Miller RL, Ponte R, Jones BR, Kinloch NN, Omondi FH, Jenabian MA, Dupuy FP, Fromentin R, Brassard P, Mehraj V, Chomont N, Poon AFY, Joy JB, Brumme ZL, Routy JP; ORCHID Study Group.

J Virol. 2019 Aug 13;93(17). pii: e00755-19. doi: 10.1128/JVI.00755-19. Print 2019 Sep 1.

PMID:
31189714
8.

Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection.

Mehraj V, Ramendra R, Isnard S, Dupuy FP, Ponte R, Chen J, Kema I, Jenabian MA, Costiniuk C, Lebouché B, Thomas R, Coté P, Leblanc R, Baril JG, Durand M, Chartrand-Lefebvre C, Tremblay C, Ancuta P, Bernard NF, Sheppard DC, Routy JP; Montreal Primary HIV-infection Study and Canadian HIV and Aging Cohort Study Groups.

Clin Infect Dis. 2019 Mar 16. pii: ciz212. doi: 10.1093/cid/ciz212. [Epub ahead of print]

PMID:
30877304
9.

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.

Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, Lebouché B, Cox J, Szabo J, Brouillette MJ, Klein MB, Chomont N, Jenabian MA.

BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.

10.

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.

Costiniuk CT, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Wasef D, Young J, de Castro C, Routy JP, Lebouché B, Cox J, Smith BM, Ambroise S, Pexos C, Patel M, Szabo J, Haraoui LP, de Pokomandy A, Tsoukas C, Falutz J, LeBlanc R, Giannakis A, Frenette C, Jenabian MA, Bourbeau J, Klein MB.

HIV Med. 2019 Mar;20(3):192-201. doi: 10.1111/hiv.12699. Epub 2019 Jan 8.

11.

HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.

Costiniuk CT, Salahuddin S, Farnos O, Olivenstein R, Pagliuzza A, Orlova M, Schurr E, De Castro C, Bourbeau J, Routy JP, Ancuta P, Chomont N, Jenabian MA.

AIDS. 2018 Oct 23;32(16):2279-2289. doi: 10.1097/QAD.0000000000001962.

12.

Anti-Gag antibodies gag HIV infection and slow disease progression.

Ahmad A, Mehraj V, Jenabian MA, Routy JP, Tremblay C.

AIDS. 2018 Jun 19;32(10):1373-1375. doi: 10.1097/QAD.0000000000001852. No abstract available.

PMID:
29851665
13.

HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation.

Allam O, Samarani S, Mehraj V, Jenabian MA, Tremblay C, Routy JP, Amre D, Ahmad A.

PLoS One. 2018 Mar 30;13(3):e0194185. doi: 10.1371/journal.pone.0194185. eCollection 2018.

14.

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study.

Costiniuk CT, Mehraj V, Routy JP, de Castro C, Wasef N, Jenabian MA, Salahuddin S, Lebouché B, Cox J, Szabo J, Klein M, Lands L, Shapiro AJ.

AIDS Res Treat. 2018 Jan 9;2018:7645125. doi: 10.1155/2018/7645125. eCollection 2018.

15.

Characterization of myeloid cell populations in human testes collected after sex reassignment surgery.

Ponte R, Dupuy FP, Brimo F, Mehraj V, Brassard P, Belanger M, Yurchenko E, Jenabian MA, Bernard NF, Routy JP; ORCHID study group.

J Reprod Immunol. 2018 Feb;125:16-24. doi: 10.1016/j.jri.2017.10.043. Epub 2017 Oct 14.

PMID:
29136520
16.

Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.

Whyte-Allman SK, Hoque MT, Jenabian MA, Routy JP, Bendayan R.

J Pharmacol Exp Ther. 2017 Dec;363(3):324-335. doi: 10.1124/jpet.117.243584. Epub 2017 Sep 28.

PMID:
28970358
17.

Potential for False-Positive Results with Serological Assays for HIV in Central Africa: Implications for the HIV Serodiagnosis Algorithm According to the 2015 Consolidated WHO Recommendations for Resource-Constrained Countries.

Jenabian MA, Costiniuk CT, Talla P, Robin L, Tonen Wolyec S, Mboumba Bouassa RS, Bélec L.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1077-1079. doi: 10.1089/AID.2017.0059. Epub 2017 Aug 16. No abstract available.

PMID:
28670913
18.

Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.

Mboumba Bouassa RS, Prazuck T, Lethu T, Jenabian MA, Meye JF, Bélec L.

Expert Rev Anti Infect Ther. 2017 Jun;15(6):613-627. doi: 10.1080/14787210.2017.1322902. Epub 2017 May 5. Review.

PMID:
28440679
19.

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.

Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Mbitikon O, Jenabian MA, Robin L, Matta M, Zeitouni K, Longo JD, Costiniuk C, Grésenguet G, Touré Kane NC, Bélec L.

Medicine (Baltimore). 2017 Mar;96(10):e6282. doi: 10.1097/MD.0000000000006282.

20.

Analytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA Quantification.

Mossoro-Kpinde CD, Mboumba Bouassa RS, Jenabian MA, Wolyec ST, Robin L, Matta M, Longo JD, Grésenguet G, Andreoletti L, Bélec L.

AIDS Res Treat. 2016;2016:7954810. doi: 10.1155/2016/7954810. Epub 2016 Dec 5.

21.

Differential synthesis and release of IL-18 and IL-18 Binding Protein from human platelets and their implications for HIV infection.

Allam O, Samarani S, Jenabian MA, Routy JP, Tremblay C, Amre D, Ahmad A.

Cytokine. 2017 Feb;90:144-154. doi: 10.1016/j.cyto.2016.10.016. Epub 2016 Dec 1.

PMID:
27914933
22.

A potentially protective role of IL-18 Binding Protein in HIV-infected Long-Term Non-Progressors.

Iannello A, Samarani S, Allam O, Jenabian MA, Mehraj V, Amre D, Routy JP, Tremblay C, Ahmad A.

Cytokine. 2017 Feb;90:96-99. doi: 10.1016/j.cyto.2016.10.018. Epub 2016 Nov 16.

PMID:
27863336
23.

Evaluation of the Upgraded Version 2.0 of the Roche COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qualitative Assay in Central African Children.

Mossoro-Kpinde CD, Jenabian MA, Gody JC, Robin L, Talla P, Longo J, Grésenguet G, Belec L.

Open AIDS J. 2016 Aug 5;10:158-163. eCollection 2016.

24.

Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.

Jenabian MA, Costiniuk CT, Mehraj V, Ghazawi FM, Fromentin R, Brousseau J, Brassard P, Bélanger M, Ancuta P, Bendayan R, Chomont N, Routy JP; Orchid study group.

AIDS. 2016 Nov 28;30(18):2777-2786.

PMID:
27677162
25.

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.

Wacleche VS, Goulet JP, Gosselin A, Monteiro P, Soudeyns H, Fromentin R, Jenabian MA, Vartanian S, Deeks SG, Chomont N, Routy JP, Ancuta P.

Retrovirology. 2016 Aug 24;13(1):59. doi: 10.1186/s12977-016-0293-6.

26.

Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.

Ahmad A, Mehraj V, Jenabian MA, Samarani S, Tremblay C, Routy JP.

AIDS. 2016 Jul 17;30(11):1839-41. doi: 10.1097/QAD.0000000000001168. No abstract available.

PMID:
27351927
27.

Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Huang Y, Hoque MT, Jenabian MA, Vyboh K, Whyte SK, Sheehan NL, Brassard P, Bélanger M, Chomont N, Fletcher CV, Routy JP, Bendayan R.

J Antimicrob Chemother. 2016 Jul;71(7):1954-65. doi: 10.1093/jac/dkw046. Epub 2016 Apr 13.

28.

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.

Mehraj V, Jenabian MA, Ponte R, Lebouché B, Costiniuk C, Thomas R, Baril JG, LeBlanc R, Cox J, Tremblay C, Routy JP; Montreal Primary HIV Infection, the Canadian Long-Term Non-Progressors Study Groups.

AIDS. 2016 Jun 19;30(10):1617-27. doi: 10.1097/QAD.0000000000001105.

29.

Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.

Jenabian MA, Talla F, Talla P, Mbopi-Kéou FX, Charpentier C, Kane CT, Bélec L.

Niger Med J. 2015 Nov-Dec;56(6):420-4. doi: 10.4103/0300-1652.171613.

30.

Imbalanced production of IL-18 and its antagonist in human diseases, and its implications for HIV-1 infection.

Samarani S, Allam O, Sagala P, Aldabah Z, Jenabian MA, Mehraj V, Tremblay C, Routy JP, Amre D, Ahmad A.

Cytokine. 2016 Jun;82:38-51. doi: 10.1016/j.cyto.2016.01.006. Epub 2016 Feb 16. Review.

PMID:
26898120
31.

Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects.

Aounallah M, Dagenais-Lussier X, El-Far M, Mehraj V, Jenabian MA, Routy JP, van Grevenynghe J.

Cytokine Growth Factor Rev. 2016 Apr;28:1-10. doi: 10.1016/j.cytogfr.2016.01.001. Epub 2016 Jan 27. Review.

PMID:
26851985
32.

Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.

Cleret-Buhot A, Zhang Y, Planas D, Goulet JP, Monteiro P, Gosselin A, Wacleche VS, Tremblay CL, Jenabian MA, Routy JP, El-Far M, Chomont N, Haddad EK, Sekaly RP, Ancuta P.

Retrovirology. 2015 Dec 10;12:102. doi: 10.1186/s12977-015-0226-9.

33.

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.

Jenabian MA, Mehraj V, Costiniuk CT, Vyboh K, Kema I, Rollet K, Paulino Ramirez R, Klein MB, Routy JP.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):254-62. doi: 10.1097/QAI.0000000000000859.

34.

Tackling virological failure in HIV-infected children living in Africa.

Jenabian MA, Costiniuk CT, Mboumba Bouassa RS, Chapdeleine Mekue Mouafo L, Brogan TV, Bélec L.

Expert Rev Anti Infect Ther. 2015;13(10):1213-23. doi: 10.1586/14787210.2015.1068117. Epub 2015 Jul 23. Review.

PMID:
26204960
35.

Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression.

Hubert A, Subra C, Jenabian MA, Tremblay Labrecque PF, Tremblay C, Laffont B, Provost P, Routy JP, Gilbert C.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):219-27. doi: 10.1097/QAI.0000000000000756.

36.

Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.

Routy JP, Mehraj V, Vyboh K, Cao W, Kema I, Jenabian MA.

AIDS Rev. 2015 Apr-Jun;17(2):96-106. Review.

PMID:
26035167
37.

Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.

LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L; ANRS12-12 Study Group.

Clin Microbiol Infect. 2015 Sep;21(9):873.e1-9. doi: 10.1016/j.cmi.2015.05.014. Epub 2015 May 21.

38.

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054).

Trottier B, Galanakis C, Longpré D, Dion H, Vézina S, Lavoie S, Boissonnault M, Costiniuk C, Jenabian MA, Machouf N, Thomas R.

HIV Clin Trials. 2015 May-Jun;16(3):111-6. doi: 10.1179/1528433614Z.0000000015.

PMID:
25997535
39.

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.

DaFonseca S, Niessl J, Pouvreau S, Wacleche VS, Gosselin A, Cleret-Buhot A, Bernard N, Tremblay C, Jenabian MA, Routy JP, Ancuta P.

Retrovirology. 2015 Apr 30;12:38. doi: 10.1186/s12977-015-0164-6.

40.

HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.

Vyboh K, Jenabian MA, Mehraj V, Routy JP.

J Immunol Res. 2015;2015:614127. doi: 10.1155/2015/614127. Epub 2015 Feb 22. Review.

41.

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy.

Mehraj V, Jenabian MA, Vyboh K, Routy JP.

Open AIDS J. 2014 Dec 29;8:66-78. doi: 10.2174/1874613601408010066. eCollection 2014.

42.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, Baril JG, LeBlanc R, Kanagaratham C, Radzioch D, Allam O, Ahmad A, Lebouché B, Tremblay C, Ancuta P, Routy JP; Montreal Primary infection and Slow Progressor Study Groups.

J Infect Dis. 2015 Aug 1;212(3):355-66. doi: 10.1093/infdis/jiv037. Epub 2015 Jan 23.

PMID:
25616404
43.

HIV reservoir dynamics in the face of highly active antiretroviral therapy.

Costiniuk CT, Jenabian MA.

AIDS Patient Care STDS. 2015 Feb;29(2):55-68. doi: 10.1089/apc.2014.0173. Epub 2014 Nov 20.

PMID:
25412339
44.

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.

Lebouché B, Jenabian MA, Singer J, Graziani GM, Engler K, Trottier B, Thomas R, Brouillette MJ, Routy JP.

Trials. 2014 Oct 7;15:390. doi: 10.1186/1745-6215-15-390.

45.

Cell-to-cell transfer of HIV infection: implications for HIV viral persistence.

Costiniuk CT, Jenabian MA.

J Gen Virol. 2014 Nov;95(Pt 11):2346-55. doi: 10.1099/vir.0.069641-0. Epub 2014 Aug 21. Review.

PMID:
25146006
46.

Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Jenabian MA, Patel M, Kema I, Vyboh K, Kanagaratham C, Radzioch D, Thébault P, Lapointe R, Gilmore N, Ancuta P, Tremblay C, Routy JP.

Clin Exp Immunol. 2014 Oct;178(1):102-11. doi: 10.1111/cei.12396.

47.

Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.

Routy JP, Angel JB, Patel M, Kanagaratham C, Radzioch D, Kema I, Gilmore N, Ancuta P, Singer J, Jenabian MA.

HIV Med. 2015 Jan;16(1):48-56. doi: 10.1111/hiv.12171. Epub 2014 Jun 2.

48.

Short communication: Lower baseline CD4 count is associated with a greater propensity toward virological failure in a cohort of South African HIV patients.

Costiniuk CT, Sigal A, Jenabian MA, Nijs P, Wilson D.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):531-4. doi: 10.1089/AID.2014.0011.

PMID:
24803320
49.

Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication.

Bernier A, Cleret-Buhot A, Zhang Y, Goulet JP, Monteiro P, Gosselin A, DaFonseca S, Wacleche VS, Jenabian MA, Routy JP, Tremblay C, Ancuta P.

Retrovirology. 2013 Dec 21;10:160. doi: 10.1186/1742-4690-10-160.

50.

HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.

Carrière M, Lacabaratz C, Kök A, Benne C, Jenabian MA, Casartelli N, Hüe S, Hocqueloux L, Lelièvre JD, Lévy Y.

J Infect Dis. 2014 May 1;209(9):1321-30. doi: 10.1093/infdis/jit643. Epub 2013 Dec 19.

PMID:
24357632

Supplemental Content

Loading ...
Support Center